(Q33636714)

28 July 2017

1 reference

title

Thrombophilia: disorders predisposing to venous thromboembolism (English)

1 reference

28 July 2017

1 reference

venous thromboembolism

1 reference

Pineo GF

1

1 reference

28 July 2017

Hull RD

series ordinal

2

1 reference

28 July 2017

publication date

1 September 1998

1 reference

Best Practice and Research: Clinical Haematology

28 July 2017

published in

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

525-540

1 reference

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Plasma Homocysteine Levels in Patients With Deep Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Natural inhibitors of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

The protein C anticoagulant system: inherited defects as basis for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Thrombomodulin Biology and potential cardiovascular applications

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Factor XI activation in a revised model of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Resistance to activated protein C: a common inherited cause of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Deficiency of protein C in congenital thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Congenital antithrombin III deficiency. Incidence and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

The antiphospholipid syndrome: ten years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Endothelial cells and the biology of factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

A prothrombin gene mutation is significantly associated with venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Absence of thrombosis in subjects with heterozygous protein C deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

World distribution of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Resistance to activated protein C as a basis for venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

The lupus anticoagulant and its role in thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Laboratory identification of the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980082-6

7 January 2021

10.1016/S0950-3536(98)80082-6

Identifiers

DOI

1 reference

release_t2z623onwjebzndbogm2ombsxu

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t2z623onwjebzndbogm2ombsxu

24 November 2022

mapped directly with Wikidata item

1 reference